Allianzgi Convertible & Income F (NYSE:NCZ) Shorted Shares Increased 44.95% After Market Selling

The stock of Allianzgi Convertible & Income F (NYSE:NCZ) registered an increase of 44.95% in short interest. NCZ’s total short interest was 210,900 shares in March as published by FINRA. Its up 44.95% from 145,500 shares, reported previously. With 306,800 shares average volume, it will take short sellers 1 days to cover their NCZ’s short positions. The stock increased 0.20% or $0.01 on March 21, hitting $4.89. Allianzgi Convertible & Income Fund II (NYSE:NCZ) has declined 26.80% since August 14, 2015 and is downtrending. It has underperformed by 24.89% the S&P500.

AllianzGI Convertible & Income Fund II is a closed-end fund. The company has a market cap of $364.22 million. The Fund investment objective is to provide total return through a combination of capital appreciation and high current income. It currently has negative earnings. The Funds attempt to achieve this objective by investing in a portfolio of convertible securities and non-convertible income-producing securities.

The institutional sentiment increased to 1.78 in Q3 2015. Its up 0.50, from 1.28 in 2015Q2. The ratio increased, as 5 funds sold all Allianzgi Convertible & Income Fund II shares owned while 13 reduced positions. 15 funds bought stakes while 17 increased positions. They now own 6.41 million shares or 27.18% more from 5.04 million shares in 2015Q2.

Doliver Capital Advisors Inc. holds 2.2% of its portfolio in Allianzgi Convertible & Income Fund II for 560,973 shares. Investors Capital Advisory Services owns 662,354 shares or 0.7% of their US portfolio. Moreover, Cornerstone Advisors Inc has 0.37% invested in the company for 295,600 shares. The New York-based Metlife Securities Inc has invested 0.12% in the stock. Landscape Capital Management L.L.C., a New Jersey-based fund reported 120,099 shares.

Allianzgi Convertible & Income Fund II - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Add Comment